ClinicalTrials.Veeva

Menu

First- or Second- Class Compression Hosiery After Endovenous Laser With Sclerotherapy and Ambulatory Phlebectomy (FISCHER)

M

Moscow City Hospital named after A.K. Eramishantsev

Status

Enrolling

Conditions

Great Saphenous Vein (GSV) With Venous Reflux Disease
Chronic Venous Insufficiency (CVI)
Venous Reflux
Chronic Venous Disorder
Varicose Veins

Treatments

Device: class I compression stockings of the RAL-GZ 387 standard: 1 month using
Device: class II compression stockings of the RAL-GZ 387 standard: 1 month using

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Investigators hypothesize that first class compression therapy during the postoperative period will improve patient adherence due to easier application and reduced discomfort. Therefore, planning to compare the effectiveness of fist class versus second class compression therapy two weeks after EVLA of the great saphenous vein with concomitant combined sclerotherapy and ambulatory phlebectomy of tributaries.

Full description

In recent decades, significant advancements have emerged in varicose vein treatment. Endovenous laser ablation (EVLA) and radiofrequency ablation (RFA) have become the leading techniques for eliminating trunk reflux, while microfoam sclerotherapy and ambulatory phlebectomy are most commonly used for treating tributaries. Post-intervention, patients typically receive recommendations to wear second-class compression stockings to reduce postoperative pain, ecchymosis, and hematomas. However, the optimal duration, regimen, and compression class remain poorly defined. Meanwhile, a growing surgical community advocates for eliminating compression therapy during the postoperative period altogether, citing low patient compliance rates (15-74%). The primary factors driving non-compliance include discomfort while wearing hosiery and difficulties with donning and doffing, suggesting compression hosiery characteristics may significantly impact adherence. Recent meta-analyses support compression therapy's benefits, demonstrating reduced postoperative pain levels and faster return to normal activities among patients using postoperative compression. Additionally, both national and international clinical guidelines recommend compression therapy for at least one week following thermal ablations. Investigators hypothesize that first class compression therapy during the postoperative period will improve patient adherence due to easier application and reduced discomfort. Therefore, planning to compare the effectiveness of first class versus second class compression therapy two weeks after EVLA of the great saphenous vein with concomitant combined sclerotherapy and ambulatory phlebectomy of tributaries.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥18 years
  • Varicose veins of the lower extremities (CEAP classification C2-C5)
  • Varicose disease in the great saphenous vein (GSV) and its tributaries
  • Planned endovenous laser ablation of the GSV trunk with concomitant combined sclerotherapy and phlebectomy of tributaries
  • Technical success of intervention (complete ablation of the GSV)
  • Signed informed consent for study participation

Exclusion criteria

  • Primary reflux outside the GSV trunk
  • History of or acute deep vein thrombosis
  • Deep vein insufficiency
  • GSV recanalization post-intervention
  • Clinical class C6 of chronic venous disease (CVD) according to CEAP classification
  • Contraindications or limitations for prolonged compression therapy, including but not limited to chronic arterial diseases of the lower extremities (any severity), skin diseases
  • Pathological conditions of lower limbs causing non-venous pain
  • Use of vasoactive medications within 1 month before/after surgery
  • Refusal to participate in the study

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

100 participants in 2 patient groups

Class 1 (18-21 mm Hg at the ankle level) above-knee graduated compression stockings
Experimental group
Description:
All participants will undergo measurement of the affected limb at standard points to select the appropriate size of compression stockings. Then, the clinical class of chronic venous disease will be assessed for the study participants according to the CEAP classification, the severity of chronic venous disease will be evaluated using the VCSS scale, quality of life will be measured using the CIVIQ-20 questionnaire, and the intensity of venous-specific symptoms will be assessed using a numerical rating scale. After the surgical intervention, a class 1 compression stocking will be put on, which they will wear continuously for 24 hours; thereafter, it must be worn during the daytime for 28 days. Upon discharge, patients will receive a diary in which they will record postoperative pain and the fact of wearing the compression garment each day for 14 days. Follow-up visits will be scheduled for 14 days and 28 days after the surgical intervention.
Treatment:
Device: class I compression stockings of the RAL-GZ 387 standard: 1 month using
Class 2 (23-32 mm Hg at the ankle level) above-knee graduated compression stockings
Active Comparator group
Description:
All participants will undergo measurement of the affected limb at standard points to select the appropriate size of compression stockings. Then, the clinical class of chronic venous disease will be assessed for the study participants according to the CEAP classification, the severity of chronic venous disease will be evaluated using the VCSS scale, quality of life will be measured using the CIVIQ-20 questionnaire, and the intensity of venous-specific symptoms will be assessed using a numerical rating scale. After the surgical intervention, a class 2 compression stocking will be put on, which they will wear continuously for 24 hours; thereafter, it must be worn during the daytime for 28 days. Upon discharge, patients will receive a diary in which they will record postoperative pain and the fact of wearing the compression garment each day for 14 days. Follow-up visits will be scheduled for 14 days and 28 days after the surgical intervention.
Treatment:
Device: class II compression stockings of the RAL-GZ 387 standard: 1 month using

Trial contacts and locations

1

Loading...

Central trial contact

Hovsep P. Manjikian, MD; Boris Danelian, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems